Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Effect of PSI697, a Small Molecule Inhibitor of P-Selectin, in the Townes Model of Sickle Cell Disease

Reema Jasuja, Sunita Patel Hett, Neelu Kaila, Debra Pittman

Blood (2015) 126 (23): 3391.

https://doi.org/10.1182/blood.V126.23.3391.3391

Published: 2015

Journal Articles

PDE-9 Inhibition Combined with Hydroxyurea Is Beneficial in Vaso-Occlusive Crisis in Mouse Model of Sickle Cell Disease

Reema Jasuja, Sunita Patel Hett, Joachim Fruebis, PhD, Debra Pittman

Blood (2014) 124 (21): 2694.

https://doi.org/10.1182/blood.V124.21.2694.2694

Published: 2014

Journal Articles

A Systems Biology Model for the Coagulation Network in Non-Bleeding State Describes Baseline Activity of Coagulation

Dooyoung Lee, PhD, Satyaprakash Nayak, PhD, Debra Pittman, Steven Arkin, MD, Steven Martin, PhD, Anne C Heatherington, PhD, Paolo Vicini, PhD, Fei Hua, PhD

Blood (2014) 124 (21): 4238.

https://doi.org/10.1182/blood.V124.21.4238.4238

Published: 2014

Journal Articles

Zymogen-like FXa Is a Potent Bypassing Agent for Reversal of Direct FXa Inhibitors in Vivo

Nabil K. Thalji, BS, Lacramioara Ivanciu, PhD, Reema Jasuja, Sunita Patel-Hett, PhD, Joachim Fruebis, PhD, Debra Pittman, Rodney M. Camire, PhD

Blood (2014) 124 (21): 582.

https://doi.org/10.1182/blood.V124.21.582.582

Published: 2014

Journal Articles

A Zymogen-like Factor Xa Improves Hemostasis in a Murine Bleeding Model

Jasuja Reema, PhD, Sunita Patel-Hett, PhD, Rodney M. Camire, PhD, Joachim Fruebis, PhD, Debra Pittman

Blood (2014) 124 (21): 1476.

https://doi.org/10.1182/blood.V124.21.1476.1476

Published: 2014

Journal Articles

Zymogen-Like FXa Is An Effective Pro-Hemostatic To Reverse The Anticoagulant Effects Of Direct FXa Inhibitors

Nabil K Thalji, BS, Sunita Patel-Hett, PhD, Reema Jasuja, PhD, Joachim Fruebis, PhD, Debra Pittman, MS, Rodney M. Camire, PhD

Blood (2013) 122 (21): 2383.

https://doi.org/10.1182/blood.V122.21.2383.2383

Published: 2013

Journal Articles

A Novel FVIIa Variant with Increased Potency and Duration of Effect Compared to Wildtype FVIIa. A Study in a Dog Model of Hemophilia A

Debra Pittman, MS, Stacey Weston, PhD, Kathleen Shields, BSc, Chuenlei Parng, PhD, Steven Arkin, MD, Ed Madison, PhD, Timothy C. Nichols, MD, Joachim Fruebis, PhD

Blood (2011) 118 (21): 2252.

https://doi.org/10.1182/blood.V118.21.2252.2252

Published: 2011

NARROW

Effect of PSI697, a Small Molecule Inhibitor of P-Selectin, in the Townes Model of Sickle Cell Disease

PDE-9 Inhibition Combined with Hydroxyurea Is Beneficial in Vaso-Occlusive Crisis in Mouse Model of Sickle Cell Disease

A Systems Biology Model for the Coagulation Network in Non-Bleeding State Describes Baseline Activity of Coagulation

Zymogen-like FXa Is a Potent Bypassing Agent for Reversal of Direct FXa Inhibitors in Vivo

A Zymogen-like Factor Xa Improves Hemostasis in a Murine Bleeding Model

Zymogen-Like FXa Is An Effective Pro-Hemostatic To Reverse The Anticoagulant Effects Of Direct FXa Inhibitors

A Novel FVIIa Variant with Increased Potency and Duration of Effect Compared to Wildtype FVIIa. A Study in a Dog Model of Hemophilia A

Email alerts

ASH Publications

American Society of Hematology

Effect of PSI697, a Small Molecule Inhibitor of P-Selectin, in the Townes Model of Sickle Cell Disease

PDE-9 Inhibition Combined with Hydroxyurea Is Beneficial in Vaso-Occlusive Crisis in Mouse Model of Sickle Cell Disease

A Systems Biology Model for the Coagulation Network in Non-Bleeding State Describes Baseline Activity of Coagulation

Zymogen-like FXa Is a Potent Bypassing Agent for Reversal of Direct FXa Inhibitors in Vivo

A Zymogen-like Factor Xa Improves Hemostasis in a Murine Bleeding Model

Zymogen-Like FXa Is An Effective Pro-Hemostatic To Reverse The Anticoagulant Effects Of Direct FXa Inhibitors

A Novel FVIIa Variant with Increased Potency and Duration of Effect Compared to Wildtype FVIIa. A Study in a Dog Model of Hemophilia A

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only